Top Markets
Coin of the day
TaiGen Biopharmaceuticals Holdings Limited TaiGen Biopharmaceuticals Holdings Limited

TaiGen Biopharmaceuticals Holdings Limited

4157
Hisse Senetlerindeki Sıralama #18388
TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm... TaiGen Biopharmaceuticals Holdings Limited is a global pharmaceutical firm dedicated to pioneering innovative treatments for life-altering diseases. Its robust development pipeline features several key assets. Among these is Taigexyn (Nemonoxacin), a non-fluorinated quinolone antibiotic currently being advanced for the treatment of various bacterial infections, including community-acquired pneumonia and diabetic foot infections. The company is also progressing Burixafor, a stem cell mobilizer with applications in stem cell transplantation and chemosensitization. Further contributing to its portfolio is TG-1000, an antiviral medication designed to combat influenza A, B, and the avian influenza H7N9 strain. Additionally, Furaprevir, a hepatitis C virus (HCV) protease inhibitor, is under development for managing chronic hepatitis C. Established in 2001, TaiGen Biopharmaceuticals maintains its headquarters in Taipei City, Taiwan.
Hisse Fiyatı
$0.28078542
Piyasa Değeri
$199.87M
Değişim (1 gün)
-0.34%
Değişim (1 yıl)
-10.19%
Ülke
TW
Ticaret TaiGen Biopharmaceuticals Holdings Limited (4157)

Kategori

TaiGen Biopharmaceuticals Holdings Limited (4157) için hisse bölünme geçmişi
TaiGen Biopharmaceuticals Holdings Limited hissesi (sembol: 4157) toplamda 0 hisse bölünmesi yaşamıştır.
En son hisse bölünmesi Sep 03, 2026 tarihinde gerçekleşmiştir.
Sep 03, 2026 tarihinden önce alınan bir 4157 hissesi bugün 0 4157 hissesine eşdeğerdir.
Hisse bölünme listesi
Yıl Bölünme Çarpan Kümülatif Çarpan
Sağlanan tarihler için yeterli veri yok.
Benzer şirketler veya rakipler için hisse bölünmeleri
Şirket Hisse bölünme sayısı Kümülatif Çarpan Ülke
1 x2
US
0 -
NL
0 -
US
1 x3
AU
0 -
CH